 Subsequently the company struggled to maintain services.In March 2014 Healthcare at Home said that it was no longer accepting new ‘high risk’ patients such as those suffering from haemophilia or respiratory diseases like cystic fibrosis because it could not guarantee getting their drugs to them on time or in full.The company blamed IT issues and a ‘system failure’ relating to the firm’s outsourcing of its logistics and warehousing departments.